Ovarian Cancer Drug Pipeline Update 2012
With nearly 60,000 cases of ovarian cancer being diagnosed in the seven major markets each year, this cancer type is by no means small and therefore it remains an important secondary indication for...
View ArticleDoxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020
Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Doxil/Caelyx sales...
View ArticleOvarian Cancer – Pipeline Review, H1 2012
Ovarian Cancer – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Ovarian Cancer - Pipeline Review, H1 2012', provides an overview of the Ovarian Cancer therapeutic pipeline. This report...
View ArticleOvarian Disease – Pipeline Review, H2 2012
Ovarian Disease – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Ovarian Disease - Pipeline Review, H2 2012', provides an overview of the Ovarian Disease therapeutic pipeline. This report...
View ArticleOvarian Cancer – Pipeline Review, H2 2012
Ovarian Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Ovarian Cancer - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report...
View ArticleOvarian Cancer Global Clinical Trials Review, H2, 2012
Ovarian Cancer Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, “Ovarian Cancer Global Clinical Trials Review, H2, 2012" provides data on the Ovarian Cancer clinical...
View ArticleOvarian Cancer Partnering 2007-2012
Summary: The Ovarian Cancer Partnering 2007-2012 report provides understanding and access to the ovarian cancer partnering deals and agreements entered into by the worlds leading healthcare companies....
View ArticleOvarian Cancer Partnering 2007-2012 - Edition 1
The Ovarian Cancer Partnering 2007-2012 report provides understanding and access to the ovarian cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in...
View ArticleGlobal Ovarian Cancer Drugs Market 2011-2015
TechNavio's analysts forecast the Global Ovarian Cancer Drugs market to grow at a CAGR of 13.1 percent over the period 2011-2015. One of the key factors contributing to this market growth is the...
View ArticleOvarian Cancer Partnering 2007-2013 Edition: 1 Code: CP2201ova
The Ovarian Cancer Partnering 2007-2013 report provides understanding and access to the ovarian cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in...
View ArticleOvarian Cancer – Pipeline Review, H1 2013
Ovarian Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Ovarian Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...
View ArticleOvarian Disease – Pipeline Review, H1 2013
Ovarian Disease – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Ovarian Disease - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...
View ArticleOvarian Cancer Partnering 2007-2013 Edition: 1
Summary:The Ovarian Cancer Partnering 2007-2013 report provides understanding and access to the ovarian cancer partnering deals and agreements entered into by the worlds leading healthcare companies....
View ArticleOvarian Cancer Drug Pathway Analyzer 2013
Extra value: One year of free online updates included with this product There are today at least 303 targeted molecular therapies known to affect more than 250 specific intracellular signaling pathways...
View ArticleOvarian Cancer - Pipeline Review, H2 2013
Ovarian Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Ovarian Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...
View ArticleOvarian Cancer Global Clinical Trials Review, H2, 2013
Ovarian Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Ovarian Cancer Global Clinical Trials Review, H2, 2013" provides data on the Ovarian Cancer clinical...
View ArticleOvarian Cancer Drug Pipeline Update 2014
Extra value: One year of free online updates included with this product With nearly 60,000 cases of ovarian cancer being diagnosed in the seven major markets each year, this cancer type is by no means...
View ArticleOvarian Cancer Partnering 2009-2014 (CP2201ova Edition: 1)
The Ovarian Cancer Partnering 2009-2014 provides understanding and access to the ovarian cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report...
View ArticleOvarian Cancer Partnering 2010-2015
The Ovarian Cancer Partnering 2010-2015 report provides understanding and access to the ovarian cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in...
View Article
